PINK
CNPOF

RIV Capital Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

RIV Capital Inc Stock Price

Vitals

Today's Low:
$0.1329
Today's High:
$0.1471
Open Price:
$0.1426
52W Low:
$0.077
52W High:
$0.572
Prev. Close:
$0.134
Volume:
27497

Company Statistics

Market Cap.:
$11.97 million
Book Value:
0.813
Revenue TTM:
$6.48 million
Operating Margin TTM:
-235.04%
Gross Profit TTM:
$1.90 million
Profit Margin:
0%
Return on Assets TTM:
-2.88%
Return on Equity TTM:
-80.67%

Company Profile

RIV Capital Inc had its IPO on under the ticker symbol CNPOF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. RIV Capital Inc has a staff strength of 0 employees.

Stock update

Shares of RIV Capital Inc opened at $0.14 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.13 - $0.15, and closed at $0.14.

This is a +3.36% increase from the previous day's closing price.

A total volume of 27,497 shares were traded at the close of the day’s session.

In the last one week, shares of RIV Capital Inc have increased by +20.43%.

RIV Capital Inc's Key Ratios

RIV Capital Inc has a market cap of $11.97 million, indicating a price to book ratio of 0.2327 and a price to sales ratio of 7.9287.

In the last 12-months RIV Capital Inc’s revenue was $6.48 million with a gross profit of $1.90 million and an EBITDA of $-15140641. The EBITDA ratio measures RIV Capital Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, RIV Capital Inc’s operating margin was -235.04% while its return on assets stood at -2.88% with a return of equity of -80.67%.

In Q4, RIV Capital Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 237.9%.

RIV Capital Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into RIV Capital Inc’s profitability.

RIV Capital Inc stock is trading at a EV to sales ratio of 0.3409 and a EV to EBITDA ratio of 1.3173. Its price to sales ratio in the trailing 12-months stood at 7.9287.

RIV Capital Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$289.69 million
Total Liabilities
$6.21 million
Operating Cash Flow
$0
Capital Expenditure
$1.66 million
Dividend Payout Ratio
0%

RIV Capital Inc ended 2024 with $289.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $289.69 million while shareholder equity stood at $137.44 million.

RIV Capital Inc ended 2024 with $0 in deferred long-term liabilities, $6.21 million in other current liabilities, in common stock, $-296425000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $125.60 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $94.40 million.

RIV Capital Inc’s total current assets stands at $136.64 million while long-term investments were $23.31 million and short-term investments were $0. Its net receivables were $11000.00 compared to accounts payable of $4.28 million and inventory worth $8.37 million.

In 2024, RIV Capital Inc's operating cash flow was $0 while its capital expenditure stood at $1.66 million.

Comparatively, RIV Capital Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.14
52-Week High
$0.572
52-Week Low
$0.077
Analyst Target Price
$

RIV Capital Inc stock is currently trading at $0.14 per share. It touched a 52-week high of $0.572 and a 52-week low of $0.572. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.1 and 200-day moving average was $0.12 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1917% of the company’s stock are held by insiders while 2427% are held by institutions.

Frequently Asked Questions About RIV Capital Inc

The stock symbol (also called stock or share ticker) of RIV Capital Inc is CNPOF

The IPO of RIV Capital Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$545.2
-5
-0.91%
$0.01
-0
-18.48%
$11.7
-0.23
-1.93%
Viad Corp (VVI)
$27.34
0.34
+1.26%
$52.99
0
0%
$1272.05
-23.1
-1.78%
$0.02
0
+4.9%
$8.62
0.3
+3.61%
$10.2
0
0%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and producti

Address

40 King Street West, Toronto, ON, Canada, M5H 3Y2